ALB and Sepsis: The large randomized controlled trial, the Albumin Italian Outcome Sepsis (ALBIOS) study also reported contradictory results that albumin provided no improvement at day 28 in patients with severe sepsis [9], while the post hoc analysis of the septic shock subgroup supported a survival benefit to albumin, given the target patient population in this meta-analysis.